← Eichor
Study identifier: NCT06770517 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Exposure Therapy for Late-life Anxiety

Condition: Anxiety Disorders · Anxiety Depression  ·  Sponsor: ProPersona

PhaseNA
Planned participants170
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective is to evaluate the (cost-)effectiveness of exposure therapy (ET) delivered by trained mental health nurses (MHNs) in terms of anxiety symptoms and quality of life for late life anxiety disorders in primary care compared to usual care (UC). UC is not restricted, and the general practitioner (GP) is encouraged to work according to the guidelines of the Dutch College of GPs. Participants in the ET group will receive 30-minute ET sessions delivered by a trained mental health nurse, during 8 sessions within the span of 12 weeks. Participants will fill in questionnaires before, during and after treatment, with a 1-year follow-up. The main study parameters are anxiety severity, quality of life and societal costs.

This description comes directly from the study's public registry record.

Talk to the study team

Gert-Jan Hendriks, Professor  ·  +31510038897  ·  g.hendriks@propersona.nl

Nessa Ikani, Asst. Prof.  ·  n.ikani@tilburguniversity.edu

Always discuss trial participation with your own doctor first.

Locations (1)

RadboudUMCNederland, Nijmegen, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06770517